Fitch also downgraded the rating to “BBB” from “A” on MHG’s $59.6 million of series 2001A revenue bonds. The downgrade is based on several factors, including MHG’s sharp decline in liquidity.
In addition, Fitch assigned a “BBB” rating to MHG’s $60 million of series 2016A revenue bonds.
More articles on healthcare finance:
Florida Hospital improves revenue capture by $72.5M with CDI program
Given the choice, 34% of employees choose HDHPs
What’s your MACRA track? 4 things to know about new details in CMS’ proposed rule
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
